🇺🇸 FDA
Patent

US 11666574

Combination therapy involving diaryl macrocyclic compounds

granted A61KA61K31/166A61K31/4184

Quick answer

US patent 11666574 (Combination therapy involving diaryl macrocyclic compounds) held by TURNING POINT THERAPEUTICS, INC. expires Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TURNING POINT THERAPEUTICS, INC.
Grant date
Tue Jun 06 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
17
CPC classes
A61K, A61K31/166, A61K31/4184, A61K31/497, A61K31/506